Valuation: Getinge AB

Market Cap 5.61TCr 0 580.2Cr 507.73Cr 467.92Cr 433.71Cr 823.32Cr 55TCr 836.59Cr 2.18TCr 27TCr 2.18TCr 2.13TCr 94TCr P/E 2026 *
19.8x
P/E 2027 * 16.9x
Enterprise Value 6.48TCr 0 669.71Cr 586.06Cr 540.11Cr 500.62Cr 950.33Cr 64TCr 965.65Cr 2.52TCr 31TCr 2.51TCr 2.46TCr 1,08400Cr EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.71x
Free-Float
78.61%
Yield 2026 *
2.45%
Yield 2027 * 2.69%
1 week+3.45%
Current month+3.45%
1 month+4.05%
3 months+5.88%
6 months-9.55%
Current year-8.16%
1 week 17.3
Extreme 17.3
18.1
1 month 16.9
Extreme 16.9
18.1
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO - 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%+3.45%+7.14% - 580.79Cr
+0.03%+0.81%+28.16%-2.77% 1.25TCr
-0.86%-2.48%+61.08%+34.47% 609.95Cr
+0.52%+2.81% - - 429.41Cr
-4.84%-3.17%-36.50%+4.18% 403.95Cr
-1.74%-0.80%-27.12%-24.91% 388.59Cr
+2.31%+16.96%+4.91%-56.86% 200.6Cr
-0.93%+4.24%+28.06%+266.40% 189.26Cr
-0.50%-0.93%+58.93%-7.84% 152.8Cr
+1.34%+5.93%-11.98%-44.50% 130.98Cr
Average -0.52%+2.37%+12.52%+21.02% 417.47Cr
Weighted average by Cap. -0.67%+1.13%+16.66%+12.49%

Financials

2026 *2027 *
Net sales 3.5TCr 0 361.79Cr 316.61Cr 291.78Cr 270.45Cr 513.4Cr 34TCr 521.67Cr 1.36TCr 17TCr 1.36TCr 1.33TCr 59TCr 3.68TCr 0 380.45Cr 332.93Cr 306.83Cr 284.39Cr 539.87Cr 36TCr 548.57Cr 1.43TCr 18TCr 1.43TCr 1.4TCr 62TCr
Net income 281.74Cr 0 29Cr 25Cr 23Cr 22Cr 41Cr 2.77TCr 42Cr 109.57Cr 1.36TCr 109.38Cr 107.01Cr 4.72TCr 329.81Cr 0 34Cr 30Cr 28Cr 25Cr 48Cr 3.24TCr 49Cr 128.26Cr 1.6TCr 128.04Cr 125.27Cr 5.52TCr
Net Debt 865.58Cr 0 90Cr 78Cr 72Cr 67Cr 127.01Cr 8.49TCr 129.06Cr 336.61Cr 4.19TCr 336.04Cr 328.76Cr 14TCr 666.15Cr 0 69Cr 60Cr 56Cr 51Cr 98Cr 6.54TCr 99Cr 259.05Cr 3.23TCr 258.61Cr 253.01Cr 11TCr
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
-
Date Price Change
07/26/07 PTS 18.10 +0.56%
06/26/06 PTS 18.00 0.00%
03/26/03 PTS 18.00 +1.12%
02/26/02 PTS 17.80 +2.89%
01/26/01 PTS 17.30 -0.57%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
205.90SEK
Average target price
226.70SEK
Spread / Average Target
+10.10%

Quarterly revenue - Rate of surprise